CRIS Current Research Information System

TRERE', DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.377
AS - Asia 3.872
EU - Europa 3.292
Continente sconosciuto - Info sul continente non disponibili 295
AF - Africa 282
SA - Sud America 221
OC - Oceania 11
Totale 13.350
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.278
CN - Cina 1.074
SG - Singapore 1.034
VN - Vietnam 954
IT - Italia 783
GB - Regno Unito 614
SE - Svezia 420
DE - Germania 341
HK - Hong Kong 252
FR - Francia 184
IN - India 165
BR - Brasile 151
RU - Federazione Russa 142
UA - Ucraina 131
NL - Olanda 129
IE - Irlanda 125
CH - Svizzera 102
TG - Togo 102
BD - Bangladesh 62
CA - Canada 62
JP - Giappone 62
KR - Corea 62
ZA - Sudafrica 59
CI - Costa d'Avorio 47
AT - Austria 46
EE - Estonia 46
PL - Polonia 44
FI - Finlandia 42
HR - Croazia 41
JO - Giordania 38
BG - Bulgaria 30
PH - Filippine 29
AR - Argentina 28
BE - Belgio 23
SC - Seychelles 20
TH - Thailandia 20
TW - Taiwan 20
ID - Indonesia 18
MX - Messico 18
EU - Europa 15
IQ - Iraq 14
NG - Nigeria 13
TR - Turchia 12
EC - Ecuador 11
AU - Australia 9
SA - Arabia Saudita 9
DK - Danimarca 8
MA - Marocco 8
PK - Pakistan 8
EG - Egitto 7
TN - Tunisia 7
CL - Cile 6
CO - Colombia 6
DZ - Algeria 6
ES - Italia 6
GR - Grecia 6
LT - Lituania 6
SK - Slovacchia (Repubblica Slovacca) 6
IR - Iran 5
JM - Giamaica 5
KE - Kenya 5
PY - Paraguay 5
UZ - Uzbekistan 5
BO - Bolivia 4
PE - Perù 4
VE - Venezuela 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
KG - Kirghizistan 3
LB - Libano 3
PR - Porto Rico 3
RO - Romania 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AZ - Azerbaigian 2
CY - Cipro 2
GY - Guiana 2
HN - Honduras 2
IL - Israele 2
KW - Kuwait 2
LV - Lettonia 2
MY - Malesia 2
PS - Palestinian Territory 2
SI - Slovenia 2
ZM - Zambia 2
AD - Andorra 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
CG - Congo 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
HU - Ungheria 1
KH - Cambogia 1
Totale 13.062
Salva come PNG Salva come JPEG
Città #
Singapore 736
Ashburn 528
Southend 513
Fairfield 454
Chandler 415
Bologna 254
Woodbridge 242
Ann Arbor 239
Houston 232
San Jose 232
Hong Kong 225
Ho Chi Minh City 221
Santa Clara 216
Seattle 215
Wilmington 206
Dallas 182
Cambridge 166
Hanoi 161
Beijing 136
Princeton 134
Dublin 124
Hefei 122
Dong Ket 105
Council Bluffs 103
Lomé 102
Boardman 98
Bern 92
Los Angeles 87
New York 85
Jacksonville 82
Lauterbourg 70
Milan 63
Nanjing 60
Padova 59
Westminster 55
Seoul 48
Tokyo 48
Abidjan 47
Jinan 43
Berlin 42
Redwood City 42
Turin 39
Amman 38
Warsaw 38
Shenyang 35
Vienna 35
Helsinki 33
Da Nang 31
Nanchang 30
Sofia 30
Haiphong 29
Buffalo 27
Hebei 27
London 27
São Paulo 27
Phoenix 26
Shanghai 26
Guangzhou 24
Saint Petersburg 24
Frankfurt am Main 23
San Diego 22
Changsha 21
Brussels 20
Chicago 20
Redmond 20
Brooklyn 19
Florence 19
Redondo Beach 19
Bremen 18
Mülheim 17
Amsterdam 15
Haikou 15
Verona 15
Zhengzhou 15
Falkenstein 14
Hyderabad 14
Jiaxing 14
Abeokuta 13
Montreal 13
Olalla 13
Sherbrooke 13
Tianjin 13
Atlanta 12
Des Moines 12
The Dalles 12
Hải Dương 11
Mexico City 11
Ningbo 11
Orem 11
Boston 10
Hangzhou 10
Rome 10
Taiyuan 10
Bangkok 9
Dearborn 9
Johannesburg 9
Lappeenranta 9
Mahé 9
Bengaluru 8
Biên Hòa 8
Totale 8.396
Salva come PNG Salva come JPEG
Nome #
Combined expression levels of KDM2A and KDM2B correlate with nucleolar size and prognosis in primary breast carcinomas 307
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 291
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 279
Human dyskerin binds to cytoplasmic H/ACA-box-containing transcripts affecting nuclear hormone receptor dependence 264
DKC1 Overexpression Induces a More Aggressive Cellular Behavior and Increases Intrinsic Ribosomal Activity in Immortalized Mammary Gland Cells 260
Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate 253
Erosions or not in GORD? The potential role of oesophageal cell proliferation 247
The nucleolar size is associated to the methylation status of ribosomal DNA in breast carcinomas. 238
Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53- deficient and proficient human osteosarcoma cell lines. 236
The p53-mediated sensitivity of cancer cells to chemotherapeutic agents is conditioned by the status of the retinoblastoma protein. 235
Location of rRNA transcription to the nucleolar components: disappearance of the fibrillar centers in nucleoli of regenerating rat hepatocytes. 234
Strategies to Restore Adenosine Triphosphate (ATP) Level After More than 20 Hours of Cold Ischemia Time in Human Marginal Kidney Grafts. 234
RNA pseudouridylation in physiology and medicine: For better and for worse 225
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease 223
Novel dyskerin-mediated mechanism of p53 inactivation through defective mRNA translation. 218
Endoscopic appearance of GERD: Putative role of cell proliferation 217
Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer. 216
Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer. 214
Key role of the achievement of an appropriate ribosomal RNA complement for G1-S phase transition in H4-II-E-C3 rat hepatoma cells 211
Esophageal cell proliferation in gastroesophageal reflux disease: clinical-morphological data before and after pantoprazole. 210
The Ribosome Biogenesis-Cancer Connection 210
Epigenetic up-regulation of ribosome biogenesis and more aggressive phenotype triggered by the lack of the histone demethylase JHDM1B in mammary epithelial cells 210
Selective inhibition of rRNA transcription downregulates E2F-1: a new p53-independent mechanism linking cell growth to cell proliferation. 207
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 203
An innovative hyperbaric hypothermic machine perfusion protects the liver from experimental preservation injury 202
The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells. 202
SnoRNA U50 levels are regulated by cell proliferation and rRNA transcription. 200
SARS-CoV-2/COVID-19 testing: The tower of babel 200
The importance of being (slightly) modified: The role of rRNA editing on gene expression control and its connections with cancer 191
Erosions or not in GERD? The potential role of esophageal cell kinetics 191
MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma 190
Hyperoxia fully protects mitochondria of explanted livers 190
Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: Correlations with cholangiocarcinoma aggressiveness 190
Changes in ribosome biogenesis may induce cancer by down-regulating the cell tumor suppressor potential. 188
Relationship between the RB1 mRNA level and the expression of phosphorylated RB protein in human breast cancers: their relevance in cell proliferation activity and patient clinical outcome 187
Direct antiviral treatments for hepatitis c virus have off-target effects of oncologic relevance in hepatocellular carcinoma 185
Downregulation of rRNA synthesis by BCL-2 induces chemoresistance in diffuse large B cell lymphoma 184
Partial persistance of exercise-induced myocardial angiogenesis following 4-wk detraining in the rat. 184
High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy. 181
Assessing the Role of Trust in Information Sources, Adoption of Preventive Practices, Volunteering and Degree of Training on Biological Risk Prevention, on Perceived Risk of Infection and Usage of Personal Protective Equipment Among Italian Medical Students During the SARS-CoV-2 Pandemic 178
Primer extension coupled with fragment analysis for rapid and quantitative evaluation of 5.8S rRNA isoforms 173
The basal-like breast carcinoma phenotype is regulated by SLUG gene expression 172
Dyskerin and TERC expression may condition survival in lung cancer patients 172
Separated Siamese Twins: Intronic Small Nucleolar RNAs and Matched Host Genes May be Altered in Conjunction or Separately in Multiple Cancer Types 172
GADD45alpha expression in cirrhosis and hepatocellular carcinoma. Relationship with DNA-repair and proliferation. 170
Liquid Biopsy in the Management of Breast Cancer Patients: Where Are We Now and Where Are We Going 169
JHDM1B expression regulates ribosome biogenesis and cancer cell growth in a p53 dependent manner 169
Prognostic relevance of a novel semi-quantitative classification of Bcl2 immunohistochemical expression in human infiltrating ductal carcinomas of the breast. 167
Relationship between dyskerin expression and telomerase activity in human breast cancer. 165
Targeted cancer therapy with ribosome biogenesis inhibitors: A real possibility? 164
Treating hematological malignancies with drugs inhibiting ribosome biogenesis: When and why 162
Nucleolar size and activity are related to pRb and p53 status in human breast cancer 161
Loss of retinoblastoma tumor suppressor protein makes human breast cancer cells more sensitive to antimetabolite exposure. 160
Controversial relationship between the expression of the RB pathway components and RB protein phosphorylation in human breast cancer 156
Effects of Entothelin-1 on Human Trabecular Meshwork Cell Contraction. 155
The emerging role of RNA polymerase I transcription machinery in human malignancy: a clinical perspective. 154
What the nucleolus says to a tumour pathologist. 152
The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status 148
Nucleolus, ribosomes, and cancer. 145
MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary 144
Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate 143
Cell proliferation in breast cancer: a major determinant of clinical outcome in node-positive, but not in node-negative patients. 136
Medical students’ attitude toward robotic surgery: time to revise medical school curricula? 135
DKC1 gene mutations in human sporadic cancer. 131
Correlation between the histopathological diagnosis by AgNOR count and AgNOR area in canine mammary tumors. 129
Dyskerin depletion increases VEGF mRNA internal ribosome entry site-mediated translation. 124
5.8S rRNA forms and ribosome heterogeneity in breast cancer 101
null 101
Ribosome biogenesis and cancer 98
null 89
null 81
Parasympathetic failure and risk of subsequent coronary events in unstable angina and non-ST-segment elevation myocardial infarction 58
Circulating miR-22 Early Predicts TACE Non-Response and Targets WEE1 in Hepatocellular Carcinoma 48
Qualitative and quantitative analysis of AgNOR proteins in chemically induced rat liver carcinogenesis 38
Pharmacogenetic testing in Italy: results of a nationwide survey by the Joint Working Group for the pharmacogenetics implementation in Italy 14
Interphase Nucleolar Organiser Regions in Tumour Pathology 9
Totale 13.350
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.448
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.348 0 35 79 203 108 66 35 130 25 133 330 204
2022/20231.808 155 260 115 240 98 148 77 107 295 41 123 149
2023/2024419 37 66 24 53 23 86 27 22 18 22 30 11
2024/20251.716 86 269 147 132 277 88 172 66 19 133 54 273
2025/20264.138 336 450 322 303 476 228 351 94 943 313 172 150
2026/2027257 132 125 0 0 0 0 0 0 0 0 0 0
Totale 13.350